U.S. FDA Grants Breakthrough Therapy Designation to Trodelvy for Second-Line Treatment of Extensive-Stage Small Cell Lung Cancer
| CFCYX Fund | USD 13.85 0.06 0.44% |
Slightly above 54% of Columbia Flexible's investor base is interested to short. The analysis of overall sentiment of trading Columbia Flexible Capital mutual fund suggests that many investors are impartial at this time. Columbia Flexible's investing sentiment can be driven by a variety of factors including economic data, Columbia Flexible's earnings reports, geopolitical events, and overall market trends.
Columbia |
Gilead Sciences, Inc. today announced that the U.S. Food and Drug Administration has granted Breakthrough Therapy Designation to
Read at businesswire.com
 |
Columbia Flexible Fundamental Analysis
We analyze Columbia Flexible's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Columbia Flexible using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Columbia Flexible based on its fundamental data. In general, a quantitative approach, as applied to this mutual fund, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Year To Date Return
Year To Date Return Comparative Analysis
Columbia Flexible is currently under evaluation in year to date return among similar funds. Year to Date Return (YTD) is the total return generated from holding a security from the beginning of the current fiscal year. In other words, YTD Return represents the capital appreciation of your investments from the start of the current fiscal year.
Columbia Flexible Capital Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Columbia Flexible mutual fund to make a market-neutral strategy. Peer analysis of Columbia Flexible could also be used in its relative valuation, which is a method of valuing Columbia Flexible by comparing valuation metrics with similar companies.
Peers
Columbia Flexible Related Equities
| CUURX | Columbia Small | 1.11 | ||||
| CDIRX | Columbia Dividend | 0.91 | ||||
| CDDRX | Columbia Dividend | 0.89 | ||||
| CDDYX | Columbia Dividend | 0.89 | ||||
| CDEYX | Columbia Diversified | 0.79 | ||||
| CDAZX | Multi Manager | 0.54 | ||||
| SRINX | Columbia Porate | 0.22 | ||||
| CUSBX | Columbia Ultra | 0.00 | ||||
| CUTYX | Columbia Treasury | 0.31 | ||||
| CUTRX | Columbia Treasury | 0.31 |
Other Information on Investing in Columbia Mutual Fund
Columbia Flexible financial ratios help investors to determine whether Columbia Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Columbia with respect to the benefits of owning Columbia Flexible security.
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated |